Loading…
Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.
Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.
Sells mass-market home-care products through supermarkets and online platforms, with liquid laundry products the main line and fabric care and hand-washing products added around it. Founder Luo Qiuping controls the company, and sales are mainly in mainland China.
In one line: China's Procter & Gamble for laundry/home care.
Moat: narrow (brand, distribution). Leading, widely trusted household-cleaning brand in China with strong e-commerce distribution.
Headquarters: Guangzhou, China · Founded: 1992 · Employees: 6,514
Size Blue Moon (6993.HK) is a Hong Kong Consumer Staples company (Household/Personal Care) with a market value of $1.88B, the 432nd largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$2.65 on 6 Nov 2026.
Performance Over six months the shares fell 14.5%, against -3.2% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 6th lowest of 21 in its peer set.
Growth Revenue fell 2.4% over the last twelve months (peer median +5.4%); the operating margin is -2.0% (peer median 10.1%).
Valuation It trades at 93.6× forward earnings against a peer median of 21.0× (most expensive of 21).
Capital Return on invested capital runs 11.0 points below its cost of capital (7.5% WACC).
Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$8.25B | HK$8.41B | HK$8.56B | HK$7.32B | HK$7.95B |
| Revenue growth | — | -2% | +17% | -8% | — |
| Gross profit | HK$4.75B | HK$4.88B | HK$5.02B | HK$4.36B | HK$4.41B |
| EBITDA | HK$59.1M | -HK$206M | -HK$740M | HK$351M | HK$1.02B |
| Net income | -HK$86.1M | -HK$329M | -HK$749M | HK$325M | HK$611M |
| Free cash flow | -HK$198M | -HK$543M | -HK$1.03B | HK$657M | HK$266M |
| Capital expenditure | HK$348M | HK$191M | HK$150M | HK$92.6M | HK$289M |
| Total debt | n/a | HK$84.9M | HK$99.7M | HK$159M | HK$200M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Blue Moon 6993.HK | $1.88B | -15% | -2% | -2% | 93.6× | n/a |
| Procter & Gamble PG | $383B | +13% | +4% | 24% | 23.4× | -0.3% |
| Unilever ULVR.L | $143B | +15% | -20% | 20% | 18.4× | 8.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 6993.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +8.6% | +2.4% | 4th highest of 21 |
| 6-month return | -14.5% | -3.2% | 6th lowest of 21 |
| Distance from 52-week high | -33.3% | -26.9% | 8th lowest of 21 |
| Revenue growth (TTM) | -2.4% | +5.4% | 4th lowest of 21 |
| Operating margin | -2.0% | 10.1% | lowest of 21 |
| Forward P/E | 93.6× | 21.0× | most expensive of 21 |
| ROIC minus cost of capital | -11.0 pp | +5.9 pp | lowest of 21 |
| Net debt / EBITDA | -46.7× | -0.6× | least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |